Steen Husted

Author PubWeight™ 5.91^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.	Lancet	2016	2.10
2	Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease.	Eur Heart J	2016	1.48
3	Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.	Eur Heart J	2015	0.86
4	Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.	Eur Heart J	2015	0.80
5	Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.	Am Heart J	2016	0.78
6	Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.	Am Heart J	2015	0.77
7	Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes.	Am Heart J	2017	0.75